{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["18"],"submitter":["Schade P"],"pubmed_abstract":["<h4>Background</h4>Complete vaccination coverage is recommended by multiple sclerosis (MS) societies for patients with multiple sclerosis (pwMS) to mitigate infection risks associated with disease-modifying therapies (DMTs).<h4>Objectives</h4>To analyze vaccination coverage and its determinants in pwMS compared to healthy controls, considering vaccination hesitancy, MS-specific vaccination beliefs, trust in information sources, and the role of general practitioners (GPs).<h4>Methods</h4>This cross-sectional multicenter observational study was conducted in six German MS centers. The primary endpoint was a vaccination index (VI) comprising eight standard vaccinations (range 0-1, with higher VI indicating better vaccination coverage). Secondary endpoints included validated measures of general"],"journal":["Therapeutic advances in neurological disorders"],"pagination":["17562864241309806"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11760134"],"repository":["biostudies-literature"],"pubmed_title":["Vaccination coverage and its determinants in patients with multiple sclerosis-a multicenter cross-sectional study."],"pmcid":["PMC11760134"],"pubmed_authors":["Richter S","Hellwig K","Wagner B","Geis C","Elias-Hamp B","Becker V","Rakers F","Pelea T","Franken P","Schwab M","Schade P","Steinle J","Nguyen HA","Merkelbach S"],"additional_accession":[]},"is_claimable":false,"name":"Vaccination coverage and its determinants in patients with multiple sclerosis-a multicenter cross-sectional study.","description":"<h4>Background</h4>Complete vaccination coverage is recommended by multiple sclerosis (MS) societies for patients with multiple sclerosis (pwMS) to mitigate infection risks associated with disease-modifying therapies (DMTs).<h4>Objectives</h4>To analyze vaccination coverage and its determinants in pwMS compared to healthy controls, considering vaccination hesitancy, MS-specific vaccination beliefs, trust in information sources, and the role of general practitioners (GPs).<h4>Methods</h4>This cross-sectional multicenter observational study was conducted in six German MS centers. The primary endpoint was a vaccination index (VI) comprising eight standard vaccinations (range 0-1, with higher VI indicating better vaccination coverage). Secondary endpoints included validated measures of general","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025","modification":"2025-04-05T00:25:53.554Z","creation":"2025-04-05T00:25:53.554Z"},"accession":"S-EPMC11760134","cross_references":{"pubmed":["39866752"],"doi":["10.1177/17562864241309806"]}}